Therapy development updates
There are many ongoing clinical and laboratory studies around the world, exploring innovative approaches to treating inherited sight loss.
Search results
There are many ongoing clinical and laboratory studies around the world, exploring innovative approaches to treating inherited sight loss.
Biotechnology company ProQR has announced that two of its RNA therapy development programmes for inherited sight loss are being acquired by Laboratoires Théa, a company specialising in eye care products.
James was part of #TeamRetinaUK in 2020 when he took part in the first ever Virtual London Marathon. He talks about his experience and his motivation.
Giving a regular monthly or quarterly donation of any amount is a wonderful way to help Retina UK support the inherited sight loss community.
Our community is informed and knowledgeable about current research projects into the cause(s) of and treatments for these conditions.
Prof Mariya Moosajee at Moorfields Eye Hospital has asked us to share the message below about the clinical trial she is running. This trial is for a treatment that targets a particular section of the USH2A gene.
Tuesday 31 March 2026, 7.00pm - 8.00pm - via Zoom - Please come and join us for our Spring meeting where we are delighted to welcome our guest speaker Stuart Hann, The Blind Chocolatier who runs his own business and shop in the Lake District!
Thursday 26 February 2026, 7.00pm - 8.30pm - via Zoom - Come and join Mark Baxter and the group for our latest Men's Peer Support Group online social catch up.
Wednesday 25 February 2026, 7.00pm - 8.30pm - via Zoom - Come and join Martik and the group for our latest Young Adults online social catch up and an update on our first in-person team building activity day and focus group of the year.
We are delighted to welcome Kathy Evans as our new Chair of Trustees.